Cat. #151091
Anti-HPV16E2 [EL58]
Cat. #: 151091
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 1-2 weeks
Target: Human Papilloma virus-16 early protein 2 (HPV16 E2)
Class: Monoclonal
Application: WB
Reactivity: Human papilloma virus
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Emma Lees
Institute: University of Oxford
Tool Details
*FOR RESEARCH USE ONLY
- Name: Anti-HPV16E2 [EL58]
- Clone: EL58
- Tool type ecom: Antibodies
- Tool sub type: Primary antibody
- Class: Monoclonal
- Conjugation: Unconjugated
- Molecular weight: 175 kDa
- Strain: Balb/c
- Reactivity: Human papilloma virus
- Host: Mouse
- Application: WB
- Description: The human papilloma virus (HPV) family of DNA tumor viruses includes HPV-16 and HPV-18, which are associated with a large proportion of cervical cancer cases. E1 and E2 are proteins involved in the regulation of viral DNA replication.
- Immunogen: Bacterial recombinant protein
- Immunogen uniprot id: P00533
- Isotype: IgG1
- Myeloma used: NS0
Target Details
- Target: Human Papilloma virus-16 early protein 2 (HPV16 E2)
- Molecular weight: 175 kDa
- Target background: The human papilloma virus (HPV) family of DNA tumor viruses includes HPV-16 and HPV-18, which are associated with a large proportion of cervical cancer cases. E1 and E2 are proteins involved in the regulation of viral DNA replication.
Applications
- Application: WB
Handling
- Format: Liquid
- Concentration: 1 mg/ml
- Unit size: 100 ug
- Storage buffer: PBS with 0.02% azide
- Storage conditions: -15° C to -25° C
- Shipping conditions: Shipping at 4° C
Related Tools
- Related tools: Anti-EGFR, Recombinant [EGFR1]
References
- Finetti et al. 2015. Endocr Relat Cancer. 22(4):665-78. PMID: 26113609.
- Perillo et al. 2015. Nat Commun. 6:7874. PMID: 26219252.
- Tang et al. 2015. Oncol Rep. 34(1):350-8. PMID: 25955689.
- mPGES-1 in prostate cancer controls stemness and amplifies epidermal growth factor receptor-driven oncogenicity.
- Downregulation of CD9 promotes pancreatic cancer growth and metastasis through upregulation of epidermal growth factor on the cell surface.
- Boersma et al. 2011. J Biol Chem. 286(48):41273-85. PMID: 21979953.
- Bispecific designed ankyrin repeat proteins (DARPins) targeting epidermal growth factor receptor inhibit A431 cell proliferation and receptor recycling.
- Jensen et al. 2006. Proc Natl Acad Sci U S A. 103(32):11958-63. PMID: 16877544.
- Single-cell expression profiling of human epidermal stem and transit-amplifying cells: Lrig1 is a regulator of stem cell quiescence.
- Gullick et al. 1986. Cancer Res. 46(1):285-92. PMID: 2998607.
- Expression of epidermal growth factor receptors on human cervical, ovarian, and vulval carcinomas.
- Waterfield et al. 1982. J Cell Biochem. 20(2):149-61. PMID: 6188757.
- A monoclonal antibody to the human epidermal growth factor receptor.
